SPM Invest group

SPM Invest group represents a Czech investment entity established formally in 2016, though its foundation rests on the prior achievements of founders Slavomír Pavlíček and Marek Španěl. The organization approaches investment opportunities with a long-term perspective, seeking meaningful partnerships rather than quick returns. With a flexible industry approach, SPM nevertheless gravitates toward businesses demonstrating substantial added value and distinctive competitive advantages in their respective markets.

The investment philosophy at SPM centers on identifying and supporting companies led by passionate management teams with clear vision and dedication to their business objectives. This people-first approach reflects SPM's belief that exceptional leadership serves as the cornerstone for sustainable growth and market differentiation. Their investment strategy prioritizes quality of execution and strength of ideas over rigid industry parameters, allowing them to consider diverse opportunities across the Czech business landscape.

SPM deploys significant capital resources, with initial investments ranging from 10 million to 200 million Czech koruna (approximately €400,000 to €8 million) per opportunity. This substantial funding capacity enables the group to make meaningful contributions to portfolio companies while maintaining a focused approach to capital allocation. The investment structure is designed to provide flexible growth capital that can adapt to the specific needs and development stages of their partner businesses.

While maintaining a primary geographic focus on supporting Czech companies in their expansion efforts, SPM adopts an open-ended investment horizon that accommodates various growth trajectories. This combination of regional specificity and temporal flexibility allows the group to serve as a stable, committed partner for Czech entrepreneurs with ambitious growth plans. SPM's approach reflects a patriotic investment philosophy aimed at strengthening the Czech business ecosystem while generating sustainable returns through patient capital deployment and strategic partnership.